TABLE 1.
Characteristic | CHF (n=54) | Control (n=70) |
---|---|---|
Age, years, mean ± SD | 80.1±5.0 | 75.2±4.1 |
Men, % | 74 | 63 |
New York Heart Association class | III or IV | Not relevant |
Hypertension, % | 46 | 0 |
Diabetes, % | 25 | 0 |
Coronary artery diseases, % | 54 | 0 |
Atrial fibrillation, % | 43 | 0 |
Chronic obstructive pulmonary disease, % | 17 | 0 |
Stroke, % | 24 | 0 |
ACE inhibitors or ARB, % | 74 | 0 |
Beta-blockers, % | 78 | 0 |
Spironolactone, % | 30 | 0 |
Statin, % | 24 | 0 |
ACE Angiotensin-converting enzyme; ARB Angiotensin II receptor subtype 1 blocker